Dmitry Balyasny’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.55M | Buy |
373,284
+124,520
| +50% | +$473K | ﹤0.01% | 1955 |
|
|
2026
Q1 | $873K | Buy |
248,764
+180,726
| +266% | +$578K | ﹤0.01% | 2136 |
|
|
2025
Q4 | $186K | Sell |
68,038
-22,586
| -25% | -$52.3K | ﹤0.01% | 2898 |
|
|
2025
Q3 | $197K | Sell |
90,624
-1,417,158
| -94% | -$3.35M | ﹤0.01% | 2728 |
|
|
2025
Q2 | $2.59M | Buy |
1,507,782
+1,297,841
| +618% | +$3.23M | ﹤0.01% | 1598 |
|
|
2025
Q1 | $699K | Sell |
209,941
-2,609,858
| -93% | -$13.5M | ﹤0.01% | 2149 |
|
|
2024
Q4 | $20.9M | Sell |
2,819,799
-1,652,777
| -37% | -$15.3M | 0.03% | 646 |
|
|
2024
Q3 | $42M | Sell |
4,472,576
-67,984
| -1% | -$644K | 0.07% | 365 |
|
|
2024
Q2 | $36.4M | Buy |
4,540,560
+3,339,696
| +278% | +$35.8M | 0.06% | 388 |
|
|
2024
Q1 | $17.8M | Sell |
1,200,864
-2,725,295
| -69% | -$31.7M | 0.03% | 666 |
|
|
2023
Q4 | $31.9M | Sell |
3,926,159
-550,677
| -12% | -$2.88M | 0.06% | 423 |
|
|
2023
Q3 | $20.4M | Buy |
4,476,836
+2,937,029
| +191% | +$19.2M | 0.04% | 564 |
|
|
2023
Q2 | $10.8M | Sell |
1,539,807
-1,195,779
| -44% | -$8.56M | 0.02% | 736 |
|
|
2023
Q1 | $16.7M | Buy |
2,735,586
+2,731,832
| +72,771% | +$18.8M | 0.04% | 583 |
|
|
2022
Q4 | $24K | Sell |
3,754
-1,739,778
| -100% | -$13.6M | ﹤0.01% | 2459 |
|
|
2022
Q3 | $16.7M | Buy |
1,743,532
+233,743
| +15% | +$2.7M | 0.05% | 490 |
|
|
2022
Q2 | $16.7M | Buy |
1,509,789
+415,765
| +38% | +$5.45M | 0.05% | 484 |
|
|
2022
Q1 | $18.2M | Buy |
1,094,024
+297,189
| +37% | +$4.6M | 0.06% | 453 |
|
|
2021
Q4 | $15.2M | Sell |
796,835
-166,625
| -17% | -$3.67M | 0.05% | 510 |
|
|
2021
Q3 | $23.8M | Buy |
963,460
+354,336
| +58% | +$8.35M | 0.1% | 285 |
|
|
2021
Q2 | $15.8M | Buy |
609,124
+441,812
| +264% | +$11.5M | 0.08% | 361 |
|
|
2021
Q1 | $5.3M | Buy |
+167,312
| New | +$6.94M | 0.03% | 678 |
|
|
2020
Q4 | – | Sell |
-437,864
| Closed | -$17.4M | – | 1513 |
|
|
2020
Q3 | $14.4M | Buy |
+437,864
| New | +$13.4M | 0.11% | 279 |
|
|
2020
Q2 | – | Sell |
-355,779
| Closed | -$11.7M | – | 1306 |
|
|
2020
Q1 | $10.7M | Buy |
+355,779
| New | +$9.43M | 0.13% | 221 |
|
|
2019
Q2 | – | Sell |
-38,011
| Closed | -$361K | – | 1593 |
|
|
2019
Q1 | $361K | Sell |
38,011
-13,104
| -26% | -$127K | ﹤0.01% | 1265 |
|
|
2018
Q4 | $452K | Sell |
51,115
-93,172
| -65% | -$899K | ﹤0.01% | 1121 |
|
|
2018
Q3 | $1.62M | Buy |
144,287
+109,210
| +311% | +$1.55M | 0.01% | 1047 |
|
|
2018
Q2 | $449K | Buy |
+35,077
| New | +$513K | ﹤0.01% | 1380 |
|
Other funds holding IOVA
MFM
PAI
Dmitry Balyasny's IOVA Position: Q2 2026 in Review
Dmitry Balyasny increased its Iovance Biotherapeutics (IOVA) stake by 50% in Q2 2026, buying an estimated $473K and bringing the position to 373,284 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1955.
Dmitry Balyasny first reported a position in IOVA in Q2 2018 and has held it in 28 quarters since. The position peaked at $42M in Q3 2024. 289 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.
- Dmitry Balyasny held 373,284 shares of Iovance Biotherapeutics worth $1.55M as of Q2 2026.
- Dmitry Balyasny bought 124,520 Iovance Biotherapeutics shares in Q2 2026, an estimated $473K.
- Iovance Biotherapeutics made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #1955 holding.
- Dmitry Balyasny first reported a position in Iovance Biotherapeutics in Q2 2018 and has held it in 28 quarters since.
- Dmitry Balyasny's Iovance Biotherapeutics position peaked at $42M in Q3 2024.
- 289 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.